Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24722280)

1.

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.

Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, Zhang Y, Hua S, Fu Q, Zhao M, Chen Y, Fang W, Lv X.

Cell Death Dis. 2014 Apr 10;5:e1155. doi: 10.1038/cddis.2014.122.

PMID:
24722280
2.

Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.

Wang RF, Zhang LH, Shan LH, Sun WG, Chai CC, Wu HM, Ibla JC, Wang LF, Liu JR.

Exp Mol Pathol. 2013 Dec;95(3):350-56.

PMID:
24422232
3.

Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.

Wang RF, Zhang LH, Shan LH, Sun WG, Chai CC, Wu HM, Ibla JC, Wang LF, Liu JR.

Exp Mol Pathol. 2013 Oct 25. pii: S0014-4800(13)00125-1. doi: 10.1016/j.yexmp.2013.10.008. [Epub ahead of print]

PMID:
24512698
4.

Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.

Cohen Y, Goldenberg-Cohen N, Shalmon B, Shani T, Oren S, Amariglio N, Dratviman-Storobinsky O, Shnaiderman-Shapiro A, Yahalom R, Kaplan I, Hirshberg A.

Oral Oncol. 2011 Oct;47(10):946-50. doi: 10.1016/j.oraloncology.2011.07.013. Epub 2011 Aug 6.

PMID:
21824802
5.

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.

Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston PG, Rudland PS, El-Tanani M.

Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16.

6.

The chemokine receptor-CXCR2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma in vitro and in vivo.

Qian Y, Wang Y, Li DS, Zhu YX, Lu ZW, Ji QH, Yang G.

J Oral Pathol Med. 2014 Oct;43(9):658-66. doi: 10.1111/jop.12189. Epub 2014 Jun 23.

PMID:
24953191
7.

IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.

Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Takeyama H.

J Surg Res. 2010 May 1;160(1):90-101. doi: 10.1016/j.jss.2008.08.016. Epub 2008 Sep 13.

PMID:
19560785
8.

GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.

Lin MC, Huang MJ, Liu CH, Yang TL, Huang MC.

Oral Oncol. 2014 May;50(5):478-84. doi: 10.1016/j.oraloncology.2014.02.003. Epub 2014 Feb 28.

PMID:
24582885
9.

NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.

Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.

Biochem Biophys Res Commun. 2010 Jan 22;391(4):1785-91. doi: 10.1016/j.bbrc.2009.12.156. Epub 2010 Jan 5.

PMID:
20045673
10.

Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.

Chiang WF, Hwang TZ, Hour TC, Wang LH, Chiu CC, Chen HR, Wu YJ, Wang CC, Wang LF, Chien CY, Chen JH, Hsu CT, Chen JY.

Oral Oncol. 2013 Jun;49(6):534-41. doi: 10.1016/j.oraloncology.2013.01.003. Epub 2013 Jan 31.

PMID:
23375593
11.

Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.

Fang L, Wang H, Zhou L, Yu D.

Oral Oncol. 2011 Jan;47(1):16-21. doi: 10.1016/j.oraloncology.2010.10.010. Epub 2010 Nov 24.

PMID:
21109483
12.

Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.

Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY.

J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25.

PMID:
23647076
13.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
14.

Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.

Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.

J Exp Clin Cancer Res. 2009 Feb 26;28:28. doi: 10.1186/1756-9966-28-28.

15.

TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.

Shih MC, Chen JY, Wu YC, Jan YH, Yang BM, Lu PJ, Cheng HC, Huang MS, Yang CJ, Hsiao M, Lai JM.

Oncogene. 2012 May 10;31(19):2389-400. doi: 10.1038/onc.2011.419. Epub 2011 Sep 26.

PMID:
21996732
16.

Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.

Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC.

Mol Cancer. 2014 Nov 26;13:254. doi: 10.1186/1476-4598-13-254.

17.

Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.

Berndt A, Büttner R, Gühne S, Gleinig A, Richter P, Chen Y, Franz M, Liebmann C.

Exp Cell Res. 2014 Apr 1;322(2):402-14. doi: 10.1016/j.yexcr.2013.12.024. Epub 2014 Jan 3.

PMID:
24394543
18.

Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma.

Shan LH, Sun WG, Han W, Qi L, Yang C, Chai CC, Yao K, Zhou QF, Wu HM, Wang LF, Liu JR.

J Clin Pathol. 2012 Oct;65(10):888-95. Epub 2012 Jul 26.

PMID:
22844068
19.

Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Mukudai Y, Kondo S, Fujita A, Yoshihama Y, Shirota T, Shintani S.

Cell Oncol (Dordr). 2013 Jun;36(3):233-45. doi: 10.1007/s13402-013-0131-y. Epub 2013 Mar 26.

PMID:
23529586
20.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk